Acrylamide neurotoxicity: Neurological, morhological and molecular endpoints in animal models

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Acrylamide (AA) monomer is used in numerous chemical industries and is a contaminant in potato- and grain-based foods prepared at high temperatures. Although experimental animal studies have implicated carcinogenicity and reproductive toxicity as possible consequences of exposure, neurotoxicity is the only outcome identified by epidemiological studies of occupationally exposed human populations. Neurotoxicity in both humans and laboratory animals is characterized by ataxia and distal skeletal muscle weakness. Early neuropathological studies suggested that AA neurotoxicity was mediated by distal axon degeneration. However, more recent electrophysiological and quantitative morphometric analyses have identified nerve terminals as primary sites of AA action. A resulting defect in neurotransmitter release appears to be the pathophysiological basis of the developing neurotoxicity. Corresponding mechanistic research suggests that AA impairs release by adducting cysteine residues on functionally important presynaptic proteins. In this publication we provide an overview of recent advances in AA research. This includes a discussion of the cumulative nature of AA neurotoxicity and the putative sites and molecular mechanisms of action.

Original languageEnglish (US)
Pages (from-to)21-37
Number of pages17
JournalAdvances in Experimental Medicine and Biology
Volume561
DOIs
StatePublished - 2005

Fingerprint

Acrylamide
Animals
Animal Models
Chemical Industry
Muscle Weakness
Laboratory Animals
Ataxia
Chemical industry
Solanum tuberosum
Research
Cysteine
Neurotransmitter Agents
Axons
Toxicity
Muscle
Epidemiologic Studies
Skeletal Muscle
Monomers
Impurities
Food

Keywords

  • Distal axonopathy
  • Nerve terminals
  • Neurotoxicity
  • Protein adducts
  • Toxic neuropathy

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

@article{8d9ab535bad04061a1d29889ddca855d,
title = "Acrylamide neurotoxicity: Neurological, morhological and molecular endpoints in animal models",
abstract = "Acrylamide (AA) monomer is used in numerous chemical industries and is a contaminant in potato- and grain-based foods prepared at high temperatures. Although experimental animal studies have implicated carcinogenicity and reproductive toxicity as possible consequences of exposure, neurotoxicity is the only outcome identified by epidemiological studies of occupationally exposed human populations. Neurotoxicity in both humans and laboratory animals is characterized by ataxia and distal skeletal muscle weakness. Early neuropathological studies suggested that AA neurotoxicity was mediated by distal axon degeneration. However, more recent electrophysiological and quantitative morphometric analyses have identified nerve terminals as primary sites of AA action. A resulting defect in neurotransmitter release appears to be the pathophysiological basis of the developing neurotoxicity. Corresponding mechanistic research suggests that AA impairs release by adducting cysteine residues on functionally important presynaptic proteins. In this publication we provide an overview of recent advances in AA research. This includes a discussion of the cumulative nature of AA neurotoxicity and the putative sites and molecular mechanisms of action.",
keywords = "Distal axonopathy, Nerve terminals, Neurotoxicity, Protein adducts, Toxic neuropathy",
author = "LoPachin, {Richard M.}",
year = "2005",
doi = "10.1007/0-387-24980-X_2",
language = "English (US)",
volume = "561",
pages = "21--37",
journal = "Advances in Experimental Medicine and Biology",
issn = "0065-2598",
publisher = "Springer New York",

}

TY - JOUR

T1 - Acrylamide neurotoxicity

T2 - Neurological, morhological and molecular endpoints in animal models

AU - LoPachin, Richard M.

PY - 2005

Y1 - 2005

N2 - Acrylamide (AA) monomer is used in numerous chemical industries and is a contaminant in potato- and grain-based foods prepared at high temperatures. Although experimental animal studies have implicated carcinogenicity and reproductive toxicity as possible consequences of exposure, neurotoxicity is the only outcome identified by epidemiological studies of occupationally exposed human populations. Neurotoxicity in both humans and laboratory animals is characterized by ataxia and distal skeletal muscle weakness. Early neuropathological studies suggested that AA neurotoxicity was mediated by distal axon degeneration. However, more recent electrophysiological and quantitative morphometric analyses have identified nerve terminals as primary sites of AA action. A resulting defect in neurotransmitter release appears to be the pathophysiological basis of the developing neurotoxicity. Corresponding mechanistic research suggests that AA impairs release by adducting cysteine residues on functionally important presynaptic proteins. In this publication we provide an overview of recent advances in AA research. This includes a discussion of the cumulative nature of AA neurotoxicity and the putative sites and molecular mechanisms of action.

AB - Acrylamide (AA) monomer is used in numerous chemical industries and is a contaminant in potato- and grain-based foods prepared at high temperatures. Although experimental animal studies have implicated carcinogenicity and reproductive toxicity as possible consequences of exposure, neurotoxicity is the only outcome identified by epidemiological studies of occupationally exposed human populations. Neurotoxicity in both humans and laboratory animals is characterized by ataxia and distal skeletal muscle weakness. Early neuropathological studies suggested that AA neurotoxicity was mediated by distal axon degeneration. However, more recent electrophysiological and quantitative morphometric analyses have identified nerve terminals as primary sites of AA action. A resulting defect in neurotransmitter release appears to be the pathophysiological basis of the developing neurotoxicity. Corresponding mechanistic research suggests that AA impairs release by adducting cysteine residues on functionally important presynaptic proteins. In this publication we provide an overview of recent advances in AA research. This includes a discussion of the cumulative nature of AA neurotoxicity and the putative sites and molecular mechanisms of action.

KW - Distal axonopathy

KW - Nerve terminals

KW - Neurotoxicity

KW - Protein adducts

KW - Toxic neuropathy

UR - http://www.scopus.com/inward/record.url?scp=33644864595&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644864595&partnerID=8YFLogxK

U2 - 10.1007/0-387-24980-X_2

DO - 10.1007/0-387-24980-X_2

M3 - Article

C2 - 16438286

AN - SCOPUS:33644864595

VL - 561

SP - 21

EP - 37

JO - Advances in Experimental Medicine and Biology

JF - Advances in Experimental Medicine and Biology

SN - 0065-2598

ER -